Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -80.29% is 52% below its 5-year average of -52.84%, around the middle of its 5-year range (-148.71%–-19.64%).
11.92% above its 12-month average of -91.16%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -148.71%.
NET PROFIT MARGIN
-80.29%
NET PROFIT MARGIN AVG TTM
-91.16%
NET PROFIT MARGIN AVG 3Y
-47.53%
NET PROFIT MARGIN AVG 5Y
-52.84%
NET PROFIT MARGIN AVG 10Y
-77.39%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+11.92%
CURRENT VS 3Y AVG
-68.94%
CURRENT VS 5Y AVG
-51.96%
CURRENT VS 10Y AVG
-3.75%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-22840.00%
vs the sector median at left
Quanterix Corporation
Market Cap
$162.04M
Net Profit Margin
-80.29%
TTM Avg
-91.16%
3Y Avg
-47.53%
5Y Avg
-52.84%
Market Cap
$159.80M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.79%
Market Cap
$159.22M
Net Profit Margin
-10.40%
TTM Avg
-6.28%
3Y Avg
-16.07%
5Y Avg
-47.85%
Market Cap
$159.14M
Net Profit Margin
-257.10%
TTM Avg
-196.56%
3Y Avg
-155.96%
5Y Avg
-114.00%
Market Cap
$165.32M
Net Profit Margin
4.66%
TTM Avg
-8.57%
3Y Avg
-15.00%
5Y Avg
-10.75%
Market Cap
$156.22M
Net Profit Margin
-6.94%
TTM Avg
-8.61%
3Y Avg
-17.97%
5Y Avg
-12.59%
Market Cap
$168.10M
Net Profit Margin
-435.83%
TTM Avg
-267.41%
3Y Avg
-1429.19%
5Y Avg
-1238.68%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quanterix Corporation (QTRX) | $162.04M | -80.29% | -91.16% | -47.53% | -52.84% |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.80M | 0.00% | 0.00% | 0.00% | 0.79% |
| PepGen Inc. (PEPG)vs › | $159.78M | 0.00% | 0.00% | 0.00% | 0.00% |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | -10.40% | -6.28% | -16.07% | -47.85% |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | -257.10% | -196.56% | -155.96% | -114.00% |
| Nkarta, Inc. (NKTX)vs › | $165.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 4.66% | -8.57% | -15.00% | -10.75% |
| Inogen, Inc. (INGN)vs › | $156.22M | -6.94% | -8.61% | -17.97% | -12.59% |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | -435.83% | -267.41% | -1429.19% | -1238.68% |
| MediWound Ltd. (MDWD)vs › | $168.92M | -170.10% | -145.13% | -100.04% | -83.24% |
Operating Margin
-86.2%
Net Profit Margin
-80.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -148.71% |
| 2026-03-31 | -48.17% |
| 2025-12-31 | -52.71% |
| 2025-09-30 | -83.48% |
| 2025-06-30 | -122.73% |
| 2025-03-31 | -67.73% |
| 2024-12-31 | -34.09% |
| 2024-09-30 | -23.59% |
| 2024-06-30 | -21.65% |
| 2024-03-31 | -35.11% |
| 2023-12-31 | -39.78% |
| 2023-09-30 | -21.62% |
| 2023-06-30 | -19.64% |
| 2023-03-31 | -21.62% |
| 2022-12-31 | -72.55% |
| 2022-09-30 | -133.00% |
| 2022-06-30 | -106.31% |
| 2022-03-31 | -61.43% |
| 2021-12-31 | -66.12% |
| 2021-09-30 | -58.70% |
| 2021-06-30 | -46.89% |
| 2021-03-31 | -37.13% |
| 2020-12-31 | -37.58% |
| 2020-09-30 | 7.48% |
| 2020-06-30 | -93.69% |
| 2020-03-31 | -73.82% |
| 2019-12-31 | -68.84% |
| 2019-09-30 | -66.05% |
| 2019-06-30 | -78.04% |
| 2019-03-31 | -76.23% |
| 2018-12-31 | -81.30% |
| 2018-09-30 | -72.30% |
| 2018-06-30 | -84.96% |
| 2018-03-31 | -143.64% |
| 2017-12-31 | -112.04% |
| 2017-09-30 | -115.35% |
| 2017-06-30 | -127.22% |
| 2017-03-31 | -119.73% |
| 2016-12-31 | -109.51% |
| 2016-09-30 | -194.89% |
| 2016-06-30 | -202.35% |
| 2016-03-31 | -137.56% |
